Literature DB >> 1496793

Ascaris suum--vaccination of mice with liposome encapsulated antigen.

S Lukes1.   

Abstract

Vaccination with liposome encapsulated adult crude antigen with and without coencapsulated immunomodulator (levamisole) in a mice/larval Ascaris suum model provided protection against a challenge infection (2000 eggs) in mice immunised by immobilised antigen. The best results (88.9% protection) were obtained with a combination of two doses of liposome entrapped antigen with leamisole. Vaccination with liposome vaccine without modulator was slightly less effective (78.7% protection). A single dose of vaccine was ineffective (14.3% protection). Application of the soluble antigen without any adjuvants led to the enhancement of worm yield in lungs and liver.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1496793     DOI: 10.1016/0304-4017(92)90053-c

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

1.  A historical and systematic overview of Ascaris vaccine development.

Authors:  Ana Clara Gazzinelli-Guimarães; Pedro Gazzinelli-Guimarães; Jill E Weatherhead
Journal:  Parasitology       Date:  2021-08-09       Impact factor: 3.243

Review 2.  Advancing a multivalent 'Pan-anthelmintic' vaccine against soil-transmitted nematode infections.

Authors:  Bin Zhan; Coreen M Beaumier; Neima Briggs; Kathryn M Jones; Brian P Keegan; Maria Elena Bottazzi; Peter J Hotez
Journal:  Expert Rev Vaccines       Date:  2014-01-06       Impact factor: 5.217

3.  IgG Induced by Vaccination With Ascaris suum Extracts Is Protective Against Infection.

Authors:  Ana Clara Gazzinelli-Guimarães; Pedro Henrique Gazzinelli-Guimarães; Denise Silva Nogueira; Fabrício Marcus Silva Oliveira; Fernando Sérgio Barbosa; Chiara Cássia Oliveira Amorim; Mariana Santos Cardoso; Lucas Kraemer; Marcelo Vidigal Caliari; Milena Apetito Akamatsu; Paulo Lee Ho; Kathryn Marie Jones; Jill Weatherhead; Maria Elena Bottazzi; Peter J Hotez; Bin Zhan; Daniella Castanheira Bartholomeu; Remo Castro Russo; Lilian Lacerda Bueno; Ricardo Toshio Fujiwara
Journal:  Front Immunol       Date:  2018-11-09       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.